Authors: Friedman, HS Kerby, T Calvert, H

Citation: Hs. Friedman et al., Temozolomide and treatment of malignant glioma, CLIN CANC R, 6(7), 2000, pp. 2585-2597

Authors: Friedman, HS Petros, WP Friedman, AH Schaaf, LJ Kerby, T Lawyer, J Parry, M Houghton, PJ Lovell, S Rasheed, K Cloughsey, T Stewart, ES Colvin, OM Provenzale, JM McLendon, RE Bigner, DD Cokgor, I Haglund, M Rich, J Ashley, D Malczyn, J Elfring, GL Miller, LL

Citation: Hs. Friedman et al., Irinotecan therapy in adults with recurrent or progressive malignant glioma, J CL ONCOL, 17(5), 1999, pp. 1516-1525

Authors: Friedman, HS Kerby, T Fields, S Zilisch, JE Graden, D McLendon, RE Houghton, PJ Arbuck, S Cokgor, I Friedman, AH

Citation: Hs. Friedman et al., Topotecan treatment of adults with primary malignant glioma, CANCER, 85(5), 1999, pp. 1160-1165

Authors: Friedman, HS McLendon, RE Kerby, T Dugan, M Bigner, SH Henry, AJ Ashley, DM Krischer, J Lovell, S Rasheed, K Marchev, F Seman, AJ Cokgor, I Rich, J Stewart, E Colvin, OM Provenzale, JM Bigner, DD Haglund, MM Friedman, AH Modrich, PL

Citation: Hs. Friedman et al., DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma, J CL ONCOL, 16(12), 1998, pp. 3851-3857